Outcomes of decompression surgery for lumbar spinal stenosis in elderly diabetic patients

The purpose of this study was to assess and compare the outcome of surgical decompression for spinal stenosis in diabetic and non-diabetic elderly patients. This is a retrospective chart analysis conducted in a university affiliated referral hospital. The participants were consecutive patients, age 65 and older, undergoing laminectomy for spinal stenosis during 1990–2000. We assessed patients clinical and demographic data, procedures, perioperative complications, preoperative and postoperative pain intensity, basic activities of daily living (BADL), patients satisfaction, the need for repeated surgery, and overall mortality. A total number of 62 elderly diabetic group (DG) patients undergoing decompression surgery for spinal stenosis were compared with a sex and age-matched non-diabetic control group (CG) at baseline, and a mean of 40.3 months thereafter. We found that the DG patients had more pain (p=0.042), and suffered more frequently from neurogenic claudication (p=0.0018), motor weakness (p=0.021) and numbness of the affected limb (p=0.0069) than the CG patients. Nocturnal pain was reported in 24% of the DG patients. Pain relief was successfully achieved in both groups (p<0.001), but the patients satisfaction was greater in the non-diabetic patients (p=0.0067). Revision surgery was more frequently performed in the DG than the CG (non-significant difference), and the time interval for such a second intervention was shorter (p=0.04) in the DG. A higher rate of post-operative complications was observed in the DG (p<0.0001). It is concluded that surgical treatment of elderly diabetic patients suffering from spinal stenosis improves BADL and ameliorates pain, but the results remain worse than those observed in non-diabetics. The outcome of diabetic patients depends upon the presence of other comorbidities, concurrent diabetic neuropathy, duration of diabetes and insulin treatment. Successful postoperative pain reduction remained the strongest factor associated with patients satisfaction.     

腰椎管狭窄症合并黄韧带囊肿1例报道

正患者,男,69岁,主因"腰痛伴左下肢疼痛1年,伴间歇性跛行5个月,加重2个月"于2016年11月7日入院。患者1年前左下肢疼痛,以左臀部及大腿外后侧为重,为间断性钝痛,5个月前出现间歇性跛行,4个月核磁检查:L_(4,5)间盘水平左侧黄韧带内见一小类圆形长T1长T2信号影,边界清晰,硬膜囊受     

选择性开窗潜行减压治疗退行性腰椎管狭窄症

目的 探讨退行性腰椎管狭窄治疗的手术方式。讨论本病的病理特点和采用选择性开窗潜行减压这一术式的可行性。方法 对６３例退行性腰椎管狭窄症患者,根据其术前ＣＴ等的定位、定性、定量及术中的具体所见,针对性地选择一侧或双侧,单个或多个开窗,行潜行减压治疗,并观察其后期疗效。结果 经治疗的６３例患者,开窗潜行减压基本上达到了满意的减压效果。疗效达优２７例,占４２．８％。良３３例,占５２．４％;可３例,占４．     

下胸椎黄韧带骨化症合并腰椎管狭窄症的诊断与一期外科治疗

目的 探讨下胸段胸椎黄韧带骨化症合并腰椎管狭窄症的诊断和治疗特点.方法 2007年3月至2009年3月,治疗下胸段胸椎黄韧带骨化症合并腰椎管狭窄症患者11例,男4例,女7例;年龄42～71岁,平均56岁;病程6～72个月,平均42个月.所有病例均一期完成胸椎管后壁切除减压、腰椎后路减压、植骨融合内固定术.术前和末次随访时行视觉模拟评分(visual analogue score,VAS)、Oswestry功能障碍指数(Oswestry disability index,ODI)、Cobb角测量,评价患者腰背疼痛、神经功能及胸腰段角度变化.结果 手术时间200～450 min,平均273 min;术中出血量600～1800 ml,平均954 ml;术中出现脑脊液漏2例.11例患者均获得完整随访,随访时间13～36个月,平均23.7个月.术前VAS、ODI、胸腰段Cobb角分别为(7.91±0.83)分、66.36%±10.91%、5.91°±0.83°.末次随访时VAS、ODI分别为(2.18±1.90)分和25.45%±12.19%,均较术前有明显改善;Cobb角度为12.18°±3.06°,较术前显著增大,出现病理性后凸.结论 下胸段胸椎黄韧带骨化症临床表现复杂,合并腰椎管狭窄症时容易漏诊.一旦诊断明确可一期行手术治疗,术后效果佳;对于女性骨质疏松患者,建议在行下胸段椎管后壁切除减压的同时行植骨融合内固定,以免造成胸腰段病理性后凸.     

棘突劈开、单侧进入双侧减压与椎板切除减压治疗退变性腰椎管狭窄症的比较

目的 比较棘突劈开、单侧进入双侧减压与椎板切除、椎管减压治疗腰椎管狭窄症的疗效.方法 前瞻性研究2009年6月至2010年5月手术治疗56例退变性腰椎管狭窄症或椎管狭窄合并间盘突出患者资料.术前随机将患者分为棘突劈开、单侧进入双侧减压组(简称棘突劈开组)及传统腰椎椎板切除、椎管减压组(简称椎板切除组).棘突劈开组共27例,男15例,女12例;年龄49～71岁,平均59.4岁.椎板切除组29例,男18例,女11例;年龄52～69岁,平均61.1岁.术后第3天行血肌酸激酶测定.应用日本矫形外科学会(Japanese Orthopaedic Association,JOA)腰痛评分及疼痛视觉模拟评分(visual analogue scale,VAS)作为手术前后主、客观评分标准.术后6个月CT扫描评价棘突愈合情况.测量术前及末次随访时多裂肌MR面积.结果 棘突劈开组21例、椎板切除组24例获得2年以上有效随访.棘突劈开组术前腰痛及下肢痛VAS、JOA评分、多裂肌MR面积分别为:(5.6±1.7)分、(7.1±0.4)分、(11.6±2.6)分、(5.8±1.8)cm2;椎板切除组分别为(6.2±1.2)分、(7.9±1.3)分、(10.9±1.0)分、(6.1±2.0) cm2.棘突劈开组术后第3天血肌酸激酶测定值明显小于椎板切除组.棘突劈开组术后6个月随访时劈开棘突均完全愈合.末次随访时棘突劈开组下肢痛VAS、JOA评分及改善率分别与椎板切除组比较均无显著性差异.棘突劈开组腰痛VAS评分、多裂肌萎缩比分别为(1.0±0.5)分、6.4％±1.2％;椎板切除组分别为(2.6±0.7)分、l5.7％±3.0％,棘突劈开组均优于椎板切除组.两组动力位X线片均未见继发性腰椎不稳.结论 棘突劈开、单侧进入双侧减压可有效减少手术创伤及术后腰痛发生率,保护双侧多裂肌棘突止点及对侧多裂肌在椎板的附着点.     

单纯减压与减压后融合治疗单纯退变性腰椎管狭窄症疗效对比研究

【摘要】 目的 比较单纯椎管减压术和减压后器械内固定融合治疗无腰椎滑脱和失稳的退变性腰椎管狭窄症的临床疗效。方法 自2006年3月~2011年5月期间,在我院接受手术治疗的单纯退变性腰椎管狭窄症患者共63例,其中接受单纯选择性椎管减压术治疗的患者28例,接受椎管减压加器械内固定融合手术患者35例。手术前后分别使用腰椎JOA (Japanese Orthopedic Association) 评分、ODI(Oswestry Disability Index)评分和SF?鄄36(Short Form?鄄36)评分,评估两种术式的临床疗效。结果 两组患者术后1年均取得较好疗效。其中椎管减压加融合组患者术后ODI评分改善31.2分(P<0.001),由重度功能障碍改善至轻度功能障碍;单纯选择性椎管减压组术后ODI评分改善14.9分(P=0.004),由重度功能障碍改善至中度功能障碍;减压加融合组预后较单纯减压组显著改善(P<0.01),术后SF?鄄36评分得到相似结果。结论 手术治疗能极大地改善腰椎管狭窄患者的临床症状,椎管减压加融合术较单纯椎管减压术能更大程度改善该类患者的临床症状。     

显微内窥镜下手术治疗退变性腰椎管狭窄症

目的 :评价显微内窥镜下手术治疗退变性腰椎管狭窄症的临床效果。方法 :用METRX手术系统对 2 3例退变性腰椎管狭窄症患者在显微内窥镜下行手术减压 ,以ODI(oswestrydisabilityindex)(Version 2 0 )评分法对患者术前及术后 9个月评分 ,并综合满意度评估。结果 :术前ODI评分平均71 32± 18 6 2 ,术后平均 39 84± 17 38,Wilcoxon秩和检验手术前后ODI评分差异显著 ,手术综合满意程度 :优 11例 ,良 6例 ,可 3例 ,差 0例 ,优良率 85 %。结论 :显微内窥镜下手术减压可以治疗退变性腰椎管狭窄症 ,但应注意适应证的选择 ,微创下难以处理时应中转为常规开放手术。     

老年腰椎椎管狭窄症患者术后急性肾损伤的发生率及危险因素

目的探讨老年腰椎椎管狭窄症患者行经腰椎后路椎板切除椎间融合术后急性肾损伤(AKI)的发生率和危险因素。方法回顾性分析2017年6月—2019年6月因腰椎椎管狭窄症在本院接受后路腰椎椎板切除椎间融合术的老年(≥65岁)患者的临床资料,统计术后AKI的发生率。比较发生AKI的患者和未发生AKI的患者一般资料及术中资料,并采用单因素及多因素logistic回归模型分析术后发生AKI的危险因素。结果共纳入216例患者,其中男104例(48.15%)、女112例(51.85%),年龄65 ～ 76(69.32±3.58)岁。发生AKI 22例(10.19%),未发生AKI 194例(89.81%)。与未发生AKI的患者相比,发生AKI患者的年龄较大、术前血红蛋白和基础估计的肾小球滤过率(eGFR)较低、麻醉时间较长、术中尿量较少、术中出血量较多。单因素logistic回归分析显示,年龄、基础eGFR水平、术前血红蛋白水平、麻醉时间、术中尿量、术中出血量均为术后发生AKI的危险因素;多因素logistic回归分析显示,基础eGFR水平和术中尿量是术后发生AKI的独立危险因素。结论 AKI是老年腰椎椎管狭窄症患者术后常见并发症,基础eGFR水平和术中尿量是术后发生AKI的独立危险因素。     

开窗潜行减压治疗退行性腰椎管狭窄症

我院从90年代初以来,采用了开窗潜行减压治疗腰椎管狭窄症,取得了满意的效果.     

胸椎退变致胸髓压迫的诊断和治疗

目的 探讨胸椎退行性改变致慢性胸髓压迫症的早期诊断和治疗方法。方法 ２１例胸椎管狭窄症患者,男９例,女１２例,平均年龄４９．５岁;单纯苋韧带骨化症１６例,Ｓｃｈｅｕｅｍａｎｎ病３例,弥散性特发性骨质肥大症２例;采用ＣＴ、ＣＴＭ、ＭＲＩ及磁刺激ＭＥＰ等检查;用“揭盖法”椎管后侧壁切除及合并前方减压法手术治疗;按ＪＯＡ评分及Ｅｐｓｔｅｉｎ的标准评定手术疗效。结果 ２１例中,局灶型５例,连续型１０例,跳     

颈椎管狭窄症患者黄韧带肥厚的组织学研究及临床意义

目的：探讨颈椎管狭窄症患者黄韧带肥厚的组织学变化及其临床意义。方法：对68例颈椎管狭窄症患者肥厚的黄韧带进行组织学及免疫组化染色研究。结果：58例（85．3％）肥厚的黄韧带内有血管增生及大量炎细胞浸润；其免疫组化染色KP—1均为阳性，49例LCA染色阳性。10例（14．7％）肥厚的黄韧带组织内未见炎细胞浸润，其免疫组化染色KP—1及LCA染色均阴性。11例（16．2％）肥厚黄韧带中发现了钙化或骨化灶。本组9例术前影像学显永不稳定节段的肥厚黄韧带内均发现了炎症反应。结论：颈椎管狭窄症患者黄韧带肥厚的原因之一可能是组织中出现了慢性炎症反应；颈椎不稳定可能是造成黄韧带内炎症反应的原因之一。     

Dural lesions in decompression for lumbar spinal stenosis: incidence,risk factors and effect on outcome

Introduction  

Decompression for lumbar spinal stenosis is one of the most frequent operations on the spine today. The most common complication seems to be a peroperative dural lesion. There are few prospective studies on this complication regarding incidence and effect on long-term outcome; this is the background for the current study.     

腰椎黄韧带骨化伴腰椎管狭窄的治疗

目的:探讨腰椎黄韧带骨化伴腰椎管狭窄影像学特点和手术治疗效果。方法 :2013年1月至2016年1月治疗腰椎黄韧带骨化伴腰椎管狭窄患者9例,男5例,女4例;年龄51~63岁,平均57岁。患者均表现为间歇性跛行和下肢放射痛,CT和MRI检查提示病变部位:L4,5和L5S1双节段2例,L4,5单节段5例,L5S1单节段2例。4例单纯行椎板切除椎管减压术,5例行椎板和椎间盘切除、椎间融合及椎弓根螺钉内固定术。采用JOA评分(包括主观症状、日常活动受限度、临床体征和膀胱功能)对治疗前后的临床疗效进行评定。结果:患者术后无感染或神经损伤等并发症,9例患者均获得随访,时间12~60个月,平均24个月。末次随访腰背疼痛和下肢放射痛等明显改善,行走距离均接近正常,JOA评分较术前明显改善。结论:腰椎黄韧带骨化CT检查有特征性影像学表现,影像学表现决定具体手术方法,手术目的以最小创伤获得椎管有效减压并重建下腰椎稳定性。     

中央型腰椎管狭窄症患者黄韧带组织生化成分变化的研究

目的:通过测定中央型腰椎管狭窄症患者腰椎黄韧带胶原蛋白和蛋白多糖含量变化,观察组织显微结构改变,探讨黄韧带组织生化成分改变与中央型腰椎管狭窄症发病的相关性方法:收集中央型腰椎管狭窄症患者的腰椎黄韧带65块作为退变组,正常腰椎黄韧带27块作为对照组,采用微量羟脯氨酸测定法和硫酸-咔唑法分别测定两组黄韧带中羟脯氨酸及糖醛酸吸光度,并计算胶原蛋白和蛋白多糖含量;游标卡尺测量黄韧带厚度;并行HE染色和Masson染色,显微镜下观察各组组织结构改变。结果:退变组黄韧带厚度、胶原蛋白及蛋白多糖含量均高于对照组,差异有显著性(P0.05);病理学观察退变黄韧带弹性纤维排列紊乱,数量减少,胶原纤维增生。结论:退变腰椎黄韧带中胶原蛋白和蛋白多糖含量增加,黄韧带生化成分改变可能引起黄韧带厚度增加,参与中央型腰椎管狭窄症的发生。     

Histological difference in ligament flavum between degenerative lumbar canal stenosis and non-stenotic group: A prospective,comparative study

BACKGROUNDLigament flavum (LF) hypertropy is the main etiopathogenesis of lumbar canal stenosis (LCS). The purely elastic LF undergoes a morphological adaptation including a reduction in the elastic fibers and a consequent increase in the collagen content, fibrosis, cicatrization, and calcification. However, the morphometric analysis can delineate the LF in patients with LCS from those without LCS, which would help in better understanding LCS pathogenesis.AIMTo compare the histopathological changes in LF between the degenerative LCS and non-stenotic (non-LCS) group.METHODSThe present prospective study was conducted in 82 patients who were divided into two groups, namely LCS and non-LCS. Demographic details of the patients such as duration of symptoms, level of involvement, and number of segments were recorded. The LF obtained from both groups was histopathologically examined for the fibrosis score, elastic fiber degeneration, calcification, and chondroid metaplasia. Morphometrical details included a change in elastin and collagen percentages, elastin/collagen ratio, elastic fiber fragmentation, and ligamentocyte numbers. All parameters were compared between the two groups by using the independent t test, Chi-square test, and Pearson’s correlation test.RESULTSOut of 82 cases, 74 were analysed, 34 in LCS and 40 in non-LCS group. The mean ± SD age of presentation in LCS and non- LCS group was 49.2 ± 8.9 and 43.1 ± 14.3 respectively. The LCS group (n = 34) exhibited significant differences in fibrosis (P = 0.002), elastic fiber degeneration (P = 0.01), % elastic fragmentation (66.5 ± 16.3 vs 29.5 ± 16.9), % elastic, content (26.9 ± 6.7 vs 34.7 ± 8.4), % collagen content (63.6 ± 10.4 vs 54.9 ± 6.4), reduction of elastic/collagen (0.4 ± 0.1 vs 0.6 ± 0.1), and ligamentocyte number (39.1 ± 19.1 vs 53.5 ± 26.9) as compared to non-LCS group (n = 40). The calcification (P = 0.08) and Pearson’s correlation between duration and loss of elastin was not significant. The difference in LF morphology is consistent in patient’s ≥ 40 years of age among the groups as found in subgroup analysis. Similarly in the patents < 40 and > 40 in the non-LCS group.CONCLUSIONLF is vital in the pathogenesis of LCS. The purely elastic LF undergoes a morphological adaptation that includes a reduction in the elastic fibers with a consequent increase in the collagen content, fibrosis, cicatrization, and calcification. The present study provides a detailed morphometric analysis to semiquantitatively delineate the LF changes in patients with LCS from those in patients without LCS.     

Histology of the ligamentum flavum in patients with degenerative lumbar spinal stenosis

The degree of calcification as well as the structural changes of the elastic fibres in the ligamentum flavum in patients with degenerative lumbar spinal stenosis were evaluated and the results were compared to those of patients without spinal stenosis. In 21 patients (13 male, 8 female) with lumbar spinal stenosis the ligamentum flavum was removed, histologically processed and stained. The calcification, the elastic/collagenous fibre ratio as well as the configuration of the fibres were evaluated with an image analyzing computer. As a control group, 20 ligaments of 10 human corpses were processed in the same way. The results were statistically analysed using the Mann-Whitney-Wilcoxon test (α = 0.05) and the t-test (α = 0.05). Nearly all the ligaments of patients with lumbar spinal stenosis were calcified (average 0.17%, maximum 3.8%) and showed relevant fibrosis with decreased elastic/collagenous fibre ratio. There was a significant correlation between age and histological changes (P < 0.05). In the control group we only found minimal calcification in 3 of 20 segments (average 0.015%). No relevant fibrosis was found and the configuration of elastic fibres showed no pathologic changes. The results of this study illustrate the important role of histological changes of the ligamentum flavum for the aetiology of lumbar spinal stenosis. Received: 31 July 1998 Revised: 19 March 1999 Accepted: 12 April 1999     

下胸椎椎管狭窄症的临床和治疗特点

目的探讨下胸椎椎管狭窄症的发病机制、病理、临床表现及治疗的特点。方法回顾性分析自1986年6月至2005年9月收治的37例下胸椎椎管狭窄症患者,其中韧带骨化29例:16例黄韧带骨化(ossification of ligamentum flavum,OLF)、13例后纵韧带骨化(ossification of posterior longitudi-nalligament,OPLL);椎间盘突出症8例(Scheuermann病或非典型Scheuermann病);病变部位:T10,11间隙12例,T11,12间隙14例,T12L1间隙11例。观察病变节段和临床神经定位体征间的关系,评价并总结其病理特征和术后神经功能恢复情况。手术采用后路减压或经肋横突入路减压治疗,严格遵循"安全手术原则"。结果下胸椎T10,11、T11,12、T12L1病变间隙导致相应脊髓节段和神经功能不同程度的障碍,神经定位检查具有特异性:T12L1椎间病变患者不出现跟腱反射或膝反射亢进,无髌阵挛或踝阵挛,可出现Babinski征;T11,12椎间病变不出现膝反射亢进或髌阵挛,可出现跟腱反射亢进或踝阵挛及Babinski征阳性,而在T10,11椎间病变上述体征均可能出现。21例患者获完全随访,根据改良JOA评分标准,21例效果均为优良。结论下胸椎椎管狭窄症的病因多是韧带骨化或椎间盘硬突出,引起"一元化"脊髓病变,不同间隙病变有特异性表现,多数采用后路减压术可解除压迫,但应注意安全手术原则。     

经皮内窥镜下经椎间孔入路腰椎椎间融合术治疗腰椎椎管狭窄症

目的 对比分析经皮内窥镜下经椎间孔入路腰椎椎间融合术（TLIF）与单纯椎板切除术治疗腰椎椎管狭窄症（LSS）的临床疗效。方法 2018年5月-2020年5月收治LSS患者180例,采用随机数字表法分为2组,其中90例采用经皮内窥镜下TLIF治疗（内窥镜组）,其余90例采用椎板切除术治疗（对照组）。记录2组切口长度、手术时间、住院时间及切口感染、脑脊液漏、硬膜囊损伤等并发症发生情况,采用疼痛视觉模拟量表（VAS）评分评估腰腿痛程度,采用生活质量评价量表（SF-36）评分评估患者生活质量,采用改良MacNab标准评定疗效并计算疗效优良率。结果 所有手术顺利完成,所有患者随访（11.26±1.35）个月。与对照组相比,内窥镜组切口更小,手术时间、住院时间更短,差异均有统计学意义（P<0.05）。2组术后12个月腰腿痛VAS评分均较术前明显改善,差异有统计学意义（P<0.05）,组间差异无统计学意义（P>0.05）。2组术后12个月SF-36各维度评分较术前均显著提升,差异有统计学意义（P<0.05）,组间差异无统计学意义（P>0.05）。2组临床疗效优良率差异无统计学意义（P>0.05）。2组并发症发生率差异无统计学意义（P>0.05）。结论 经皮内窥镜下TLIF和椎板切除术治疗LSS均可获得良好疗效,可有效减轻患者腰腿痛程度,改善患者生活质量,但经皮内窥镜下TLIF具有创伤更小、术后恢复更快等优点,临床中可依据患者情况和意愿灵活选择。     

全椎板切除后椎板重建治疗腰椎管狭窄症

目的:观察全椎板切除椎管减压内固定术后采用硬膜外植骨重建椎板方法治疗腰椎管狭窄症的早期(术后3个月)及中期(术后＞1年)疗效.方法:选择22例中重度退行性腰椎管狭窄患者行全椎板切除椎管减压内固定术,男12例,女10例;年龄55～76岁,平均65.8岁;病变节段为L3-S1,包括单节段(6例)、双节段(13例)、三节段(3例).全椎板切除后在切除椎板间硬膜外植骨重建椎板.随访时间1～3年,分别在术前、术后3个月及末次随访时采用JOA评分从主观症状、临床体征、日常活动受限情况及膀胱功能等方面对疗效进行评价,并通过影像学检查测量椎管矢状径变化.结果:22例患者均获随访,术前、术后3个月及末次随访时JOA下腰痛评分分别为(5.3±1.6)、(23.2±2.0)、(22.9±2.4)分;术后3个月优18例,良3例,可1例;末次随访优17例,良3例,可2例.狭窄节段术前椎管矢状径为(6.8±0.9) mm,术后3个月为(17.6±2.5) mm,末次随访时为(16.9±1.8) mm.经统计学检验,JOA评分术后3个月与术前比较,差异有统计学意义(P＜0.05);末次随访与术前比较,差异也有统计学意义(P＜0.05);术后3个月和末次随访疗效比较无统计学差异(P＞0.05).椎管矢状径改变椎板重建术后3个月与术前比较有统计学差异(P＜0.05),而椎板重建术后3个月与末次随访时比较无统计学差异(P＞0.05).影像学变化:末次随访时的CT片示椎管无狭窄,神经根、硬膜囊无压迫,椎板重建后骨质已大片融合,未发现明显的骨质吸收,内固定无松动及断裂情况.结论:椎板切除后椎板间植骨重建术治疗腰椎管狭窄症可以同时达到充分减压和脊柱生物力学稳定,能有效预防术后瘢痕压迫和粘连形成椎管再狭窄,中早期疗效满意.     

合并糖尿病的腰椎管狭窄症患者手术治疗效果分析

背景：糖尿病常因合并腰椎管狭窄症而需手术治疗,若同时合并糖尿病性周围血管或神经病变,其手术效果往往会受到很大影响。但目前很少有学者对合并糖尿病的腰椎管狭窄症患者的临床疗效进行随访研究。 目的：探讨合并糖尿病的腰椎管狭窄症患者的手术治疗效果。 方法：回顾性分析2008年3月至2012年12月手术治疗的腰椎管狭窄症患者94例,分为合并糖尿病组（A组）及单纯腰椎管狭窄症组（B组）各47例。通过比较两组患者体重指数、住院时间、融合节段、手术时间、术中出血量、术后引流量、围手术期并发症发生率、术前及术后1年随访的VAS评分及JOA评分、术后1年融合率等临床指标评价糖尿病对腰椎管狭窄症患者手术疗效的影响。 结果：两组患者的性别、年龄、手术时间、术中出血量、围手术期并发症发生率、术前及术后1年随访的VAS评分及JOA评分、术后1年融合率均无统计学差异（P＞0.05）,两组患者的体重指数、住院时间、术后引流量有统计学差异（P＜0.05）。 结论：合并糖尿病的腰椎管狭窄症患者的住院时间明显延长,术后引流量增加,但手术疗效尚可。